PART I Item 1. B usiness. In this Annual Report, unless the context otherwise dictates, the terms (i) we, us, our, Sensei, the Company and other similar terms refer to the business and operations of Sensei Biotherapeutics, Inc. and its consolidated subsidiaries for periods prior to the Acquisition (as defined below) and to Sensei Biotherapeutics, Inc. and its consolidated subsidiaries, including Faeth Therapeutics for periods after the Acquisition; (ii) Faeth HoldCo refers to Faeth Holdings Ther...
Q2 FY2026 — expected 2026-08-09
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-30 | 2025-12-31 | 0001193125-26-132014 | EDGAR | 94K words |
| 2025-03-28 | 2024-12-31 | 0000950170-25-046338 | EDGAR | — |
| 2024-02-29 | 2023-12-31 | 0000950170-24-023148 | EDGAR | — |
| 2023-03-29 | 2022-12-31 | 0000950170-23-010432 | EDGAR | — |
| 2022-03-15 | 2021-12-31 | 0000950170-22-003646 | EDGAR | — |
| 2021-03-30 | 2020-12-31 | 0001564590-21-016297 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-14 | 2025-09-30 | 0001193125-25-281590 | EDGAR | 55K words |
| 2025-08-05 | 2025-06-30 | 0000950170-25-103101 | EDGAR | — |
| 2025-05-06 | 2025-03-31 | 0000950170-25-064525 | EDGAR | — |
| 2024-11-14 | 2024-09-30 | 0000950170-24-126748 | EDGAR | — |
| 2024-08-06 | 2024-06-30 | 0000950170-24-091895 | EDGAR | — |
| 2024-05-09 | 2024-03-31 | 0000950170-24-057106 | EDGAR | — |
| 2023-11-07 | 2023-09-30 | 0000950170-23-060340 | EDGAR | — |
| 2023-08-03 | 2023-06-30 | 0000950170-23-038085 | EDGAR | — |
| 2023-05-09 | 2023-03-31 | 0000950170-23-019754 | EDGAR | — |
| 2022-11-08 | 2022-09-30 | 0000950170-22-023276 | EDGAR | — |
| 2022-08-09 | 2022-06-30 | 0000950170-22-016148 | EDGAR | — |
| 2022-05-10 | 2022-03-31 | 0000950170-22-009054 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-30 | 0001193125-26-130419 | EDGAR | 1K words |
| 2026-02-18 | 0001193125-26-056135 | EDGAR | — |
| 2026-02-13 | 0001193125-26-051815 | EDGAR | — |
| 2025-12-23 | 0001193125-25-331113 | EDGAR | — |
| 2025-11-14 | 0001193125-25-281581 | EDGAR | — |
| 2025-10-30 | 0001193125-25-257621 | EDGAR | — |
| 2025-10-17 | 0001193125-25-242007 | EDGAR | — |
| 2025-08-05 | 0001193125-25-173043 | EDGAR | — |
| 2025-07-09 | 0001193125-25-157113 | EDGAR | — |
| 2025-06-13 | 0001193125-25-140329 | EDGAR | — |
105 total filings indexed. 77 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001829802 |
| Ticker | SNSE |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.senseibio.com |
| Listed | 2021-02-04 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report